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Abstract
Background: Segmentation of gliomas in multi-parametric (MP-)MR images is challenging due to their
heterogeneous nature in terms of size, appearance and location. Manual tumor segmentation is a time-consuming
task and clinical practice would benefit from (semi-) automated segmentation of the different tumor compartments.
Methods: We present a semi-automated framework for brain tumor segmentation based on non-negative matrix
factorization (NMF) that does not require prior training of the method. L1-regularization is incorporated into the NMF
objective function to promote spatial consistency and sparseness of the tissue abundance maps. The pathological
sources are initialized through user-defined voxel selection. Knowledge about the spatial location of the selected
voxels is combined with tissue adjacency constraints in a post-processing step to enhance segmentation quality. The
method is applied to an MP-MRI dataset of 21 high-grade glioma patients, including conventional,
perfusion-weighted and diffusion-weighted MRI. To assess the effect of using MP-MRI data and the L1-regularization
term, analyses are also run using only conventional MRI and without L1-regularization. Robustness against user input
variability is verified by considering the statistical distribution of the segmentation results when repeatedly analyzing
each patient’s dataset with a different set of random seeding points.
Results: Using L1-regularized semi-automated NMF segmentation, mean Dice-scores of 65%, 74 and 80% are found
for active tumor, the tumor core and the whole tumor region. Mean Hausdorff distances of 6.1 mm, 7.4 mm and 8.2
mm are found for active tumor, the tumor core and the whole tumor region. Lower Dice-scores and higher Hausdorff
distances are found without L1-regularization and when only considering conventional MRI data.
Conclusions: Based on the mean Dice-scores and Hausdorff distances, segmentation results are competitive with
state-of-the-art in literature. Robust results were found for most patients, although careful voxel selection is
mandatory to avoid sub-optimal segmentation.
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Background
High-grade gliomas (HGGs) account for 80% of all malig-
nant primary brain tumors [1]. Standard treatment of
HGG consists of complete or partial resection of the
gross tumor volume, followed by radiotherapy and/or
chemotherapy to attack the remaining tumor cells and
to counteract tumor recurrence. So far, recent advance-
ments in glioma research have only had little effect on
patient outcome. The 5 year survival rate of the most
common histopathological subtypes, anaplastic astrocy-
toma and glioblastoma multiforme (GBM) are 26 and 5%,
respectively [1].
MRI has become the imaging modality of choice for
evaluating tumor progression and the efficacy of a cho-
sen treatment strategy. GBM, the most malignant and
most common type of glioma, tends to invade the
healthy tissue, such that tumor margins extend beyond
the imageable component of the tumor based on con-
ventional MRI (cMRI). Numerous recent studies have
recommended incorporating additional imaging biomark-
ers from advanced MRI modalities such as perfusion-
weighted imaging (PWI) and diffusion-weighted imaging
(DWI) [2–4]. PWI is used for studying tumor angiogen-
esis, as HGGs are known to stimulate vascular ingrowth
[5]. PWI measurements in the peritumoral region have
been reported to differentiate GBM frommetastases, sug-
gesting the detection of tumor infiltration [6]. PWI was
also found useful in differentiating tumor recurrence from
radiation necrosis [7]. DWI assesses the mobility of water
molecules within tissue due to Brownian motion. Because
glioma infiltration disrupts the organization of the white
matter tracts, DWI is potentially useful to characterize the
extent of infiltration. Diffusion tensor imaging has been
reported to better delineate tumor margins in gliomas
than cMRI [8].
Assessment of tumor extent plays a key role at all stages
of the treatment process. An outline of the gross tumor
volume is made upon planning surgical resection and for
defining the radiotherapy target volume. During follow-
up, the response assessment in neuro-oncology (RANO)
criteria are applied for monitoring tumor growth, assess-
ing the maximal diameter of the lesion in 2 orthogonal
directions on axial slices [9]. Clinical practice would ben-
efit from volumetric measurements of the tumor and
its subcompartments. With the recent emergence of the
dose-painting concept in radiotherapy, segmentation of
the active tumor region would allow focusing the radi-
ation energy to the most active part of the tumor in a
non-uniform way [10]. Volume measures of the active
tumor and necrotic region have been reported to be
significant predictors of patient outcome to treatment
[11, 12]. Furthermore, the RANO criteria acknowledge
that volumetric measurements might be favorable com-
pared to cross product diameters in cases of irregularly
shaped tumors, multi-focal tumors and tumors with cys-
tic or necrotic components. However, segmentation of
HGGs in MRI is a challenging task, due to their hetero-
geneous nature: several stages of the disease can occur
throughout the same lesion and diffuse boundaries exist
between active tumor, necrosis, edema and the surround-
ing healthy brain. Manual segmentation of 3D images is
also time-consuming, which is the main reason why vol-
umetric tumor delineation has not become widespread in
clinical practice.
In recent years, significant advancements have been
made in the field of automated brain tumor segmentation.
Both semi-automatic and fully automatic methods have
been proposed [13]. A popular approach is to combine
imaging biomarkers from different MRI sequences on a
voxel-wise basis, thereby increasing specificity and reduc-
ing overlap between tissue classes. Nowadays, supervised
classification methods are receiving most attention [14].
These methods rely on an extensive set of training images
with manually annotated ground truth to learn deci-
sion boundaries between the tissue classes in feature
space. The most popular methods include random forests
[15, 16], support vector machines [17, 18] and neural net-
works [19]. Additional constraints may be imposed to
further enhance performance, such as spatial consistency
of the tissue regions [20, 21].
Unsupervised classification methods are also being con-
sidered for tumor segmentation. These methods are very
flexible, as they don’t require an extensive training dataset
with a uniform acquisition protocol. They learn classifica-
tion rules directly from the imaging data at hand, based
on some similarity criterion. Popular approaches include
fuzzy C-means clustering (FCM) [22, 23], Gaussian mix-
ture modeling [24, 25], hidden Markov Random Fields
[26, 27] and non-negative matrix factorization (NMF)
[28, 29]. Due to the absence of training data, unsuper-
vised methods rely more strongly on the incorporation of
prior knowledge to obtain competitive results. As gliomas
exhibit a wide variability in terms of size, shape, location
and appearance, imposing proper prior knowledge is dif-
ficult. Several studies make use of a normal brain atlas to
differentiate the pathological region from the healthy tis-
sue structures [25, 30]. This approach assumes that the
healthy brain structures are not altered by the tumor,
which might not be valid for large tumors deforming
the surrounding healthy tissue. Some studies assume the
active tumor region to be either enhancing [30] or non-
enhancing [22], or hyper-perfused [23]. These assump-
tions do not hold in general in heterogeneous gliomas with
varying degrees of contrast enhancement and/or perfu-
sion. Another approach is to detect tumors by looking at
the dissimilarity across the hemispheres, thereby suppos-
ing that the tumor volume is restricted to one of the hemi-
spheres [31]. For the removal of false positives, several
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segmentation algorithms only retain the largest connected
component in the segmentation mask, thereby assuming
only one tumor volume [22, 32]. Evidently, many unsuper-
vised segmentation studies incorporate prior knowledge
in the form of simplifying rules, limiting their applicability
to a subset of gliomas with specific characteristics. Some
methods are limited to a particular set of MRI parameters,
as they rely on one or more specific imaging biomarkers.
Semi-automated segmentation algorithms incorporate
prior knowledge in the form of user-specific input, either
as an initialization or as a post-processing step. Compet-
itive performance has been reported for semi-automated
algorithms [14]. Kwon et al. combined a normal brain
atlas with a tumor growth model [33]. User-defined seed-
ing points are used to initiate the tumor growth model,
allowing to model multi-focal gliomas as well. Hamamci
et al. initialized a cellular automata algorithm based on
the maximal tumor diameter as drawn by the user on T1C
images [34]. An active level-set surface is then initialized
from the user-defined maximal diameter, to impose spa-
tial smoothness on the contour of the pathological region.
Havaei et al. initialized a k-nearest neighbors (kNN) clas-
sifier with user-selected voxels in the tumor subcompart-
ments as well as in the healthy brain regions [35]. Spatial
coordinates of the seeding points were also exploited in
the feature set. The main drawback of semi-automated
methods is that they don’t provide reproducible results,
as the segmentation depends on subjective user input.
Robustness against user input variability is therefore a key
aspect of these methods. In the current study, we propose
a semi-automated brain tumor segmentation method
based on regularized non-negative matrix factorization.
User-defined seeding points in the pathological regions
are combined with a sophisticated seeding method for
the normal brain tissues to initialize the NMF algorithm.
Piece-wise spatial smoothness as well as sparseness of the
NMF tissue abundance maps are encouraged through L1-
regularization. Morphological post-processing based on
the spatial location of the user-defined seeds is exploited
to further remove false positives. The proposed method
is applicable to all types of gliomas with any MP-MRI
dataset, as the user-defined prior knowledge is patient-
specific. We illustrate segmentation performance on an
MP-MRI dataset of 21 HGGs combining cMRI, PWI
and DWI. To verify robustness against user input vari-
ability, each patient’s dataset is repeatedly analyzed with
randomly selected seeding points from the pathological
subcompartments.
Methods
Patient population
Twenty-one patients who were diagnosed with a HGG
were enrolled in the study: 1 grade II astrocytoma
with focal progression to grade III anaplasia, 2 grade II
oligodendrogliomas with focal progression to grade III, 1
oligo-astrocytoma with focal progression to grade III, 6
anaplastic oligo-astrocytomas, 1 anaplastic astrocytoma
with focal progression to GBM and 10 GBMs. The Ghent
University Hospital local ethics committee allowed a ret-
rospective analysis of the data.
Multi-parametric MRI dataset
The MR examinations were performed on a 3T Siemens
Trio Tim scanner (Erlangen, Germany), using a standard
12-channel phased array head coil. All patients underwent
anMP-MRI acquisition protocol, consisting of cMRI, PWI
and DWI.
cMRI consisted of a 3-dimensional T1-weighted
gradient-echo sequence (MPRAGE) before and after
contrast administration, with isotropic voxels, and a
3-dimensional T2-weighted inversion recovery sequence
(FLAIR) with isotropic voxels. An overview of the
image acquisition settings which are defined for all MRI
modalities is given in Table 1.
PWI was performed by using a lipid-suppressed, T2*-
weighted echo-planar imaging sequence. A series of 90
multi-section acquisitions was acquired at 1 second inter-
vals. The first 10 acquisitions were performed before
contrast agent injection to establish a pre-contrast base-
line. At the tenth acquisition, a 0.1 mmol/kg body weight
bolus of gadobutrol (Gadovist, Bayer) was injected with a
power injector (Spectris, Medrad Inc., Indianola, PA) at
a rate of 4 ml/s through a 18-gauge intravenous catheter,
immediately followed by a 20 ml bolus of sodium chloride
solution at 4 ml/s. Relative cerebral blood volume (rCBV)
maps were derived from the dynamic signal intensity
curves in the DSCoMAN software (Dynamic Susceptibil-
ity Contrast MR Analysis, Duke University, Durham, NC).
DSCoMAN computes rCBV based on the method pro-
posed by Boxerman et al. [36], compensating for contrast
agent leakage due to disruption of the blood-brain barrier.
The measured relaxivity change in each voxel is approxi-
mated as a linear combination of the whole-brain average
relaxivity change in non-enhancing voxels,R∗2(t), and its
time integral:
R∗2(t) ≈ K1R∗2(t) − K2
∫ t
0
R∗2(τ )dτ (1)
where R∗2(t) represents the measured relaxivity change
in a voxel. The first term reflects the uncontaminated
relaxivity change and the second term reflects the effects
of leakage. Linear least squares fitting is applied to com-
pute the weighting factors K1 and K2 over all the voxels.
Corrected relaxivity curves are obtained by only withhold-
ing the K1-term.
Axial diffusion-weighted images were acquired using
a fast single-shot gradient-echo echo-planar imaging
sequence with diffusion gradient b-values of 0, 500 and
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Table 1 Overview of the MR acquisition parameters for cMRI, PWI and DWI
TR [ms] TE [ms] TI [ms] voxel size [mm3] Field of view [mm2] Flip angle [°]
cMRI T1/T1C 1550 2.39 900 0.9×0.9×0.9 220 × 220 9
FLAIR 6000 421 2100 1.0×1.0×1.0 250 × 234.5 120
PWI 1000 29 – 1.8×1.8×1.8 230 × 230 90
DWI 5400 80 – 2.0×2.0×3.0 264 × 264 90
1000 s/mm2. The b500 and b1000 images were acquired
in 3 orthogonal directions. An affine coregistration was
applied to account for eddy currents. Apparent Diffusion
Coefficient (ADC) maps were derived from the 3 b-values
using weighted linear least squares fitting [37]:
β = (XTWX)−1XTWy (2)
where β is the diffusion model’s parameter vector, con-
taining the ADC value, X is the design matrix of all
diffusion gradients, and y is a vector containing the loga-
rithm of the signal intensities. W is a weighting matrix to
take into account the heteroscedasticity, i.e. the fact that
the lower signals in y have a higher variance, as a result of
the logarithmic transform:
W = diag(exp(2XβLLS)) (3)
where βLLS represents the initial estimate of β obtained
using standard linear least squares fitting. The raw b0
images were also added to the input dataset, serving as a
T2-weighted reference.
Six MRI features were obtained from the raw acquired
data after pre-processing: T1, T1C, FLAIR, rCBV, ADC
and b0. All MP-MRI features were coregistered and
resampled to the same spatial resolution of 1×1×3mm3.
cMRI data were skull-stripped and T1C served as a ref-
erence for rigid coregistration in SPM8 (Wellcome Trust
Centre for Neuroimaging, University College London),
using the normalized mutual information criterion [38]
and cubic B-spline interpolation for reslicing. Analyses
were performed on 10 axial slices located around the
tumor centre. Additional intensity-based features were
added to the feature set to include localized spatial infor-
mation. An in-plane local neighborhood of 3 × 3 and
5 × 5 voxels was used to calculate average intensity val-
ues that were assigned to the central voxel. These spatially
averaged intensity values were added for all MP-MRI fea-
tures. The averaged features were added in accordance
with a previous study, in which it was shown that their
inclusion significantly improved MRI-based brain tumor
segmentation [28]. The same finding was also confirmed
for the current study. Each feature’s full range was rescaled
linearly to [0–1]. A total of 18 MRI features was finally
obtained, making up the rows of the input matrix X.
Segmentation framework
Non-negativematrix factorization
NMF provides a rank-r approximation of a non-negative
input matrix X by the product of 2 non-negative factor
matrices,W and H :
X ≈ WH with X ∈ Rm×n+ ,W ∈ Rm×r+ and H ∈ Rr×n+
(4)
with m being the number of input features and n the
number of data points in X. NMF reveals an additive
parts-based structure of the input data. It represents each
column of X by a weighted sum of the r columns ofW. As
we are dealing with image intensities, the non-negativity
constraint applies naturally. Each column of X corre-
sponds to one voxel’s MP-MRI feature set. Each column of
W represents a tissue-specific signature, i.e. an MP-MRI
feature vector corresponding to one pure tissue type. As
such, each voxel’s MP-MRI feature vector is approximated
as a weighted sum of (tissue-specific) source vectors. Each
column of H represents the weights of the tissue types
for one voxel. One row of H contains the abundances of
one particular tissue type over all the voxels, which can
be transformed back into the image space to obtain a tis-
sue abundance map. The following objective function is
considered for solving the NMF problem:
min
W ,H
f (W ,H) = min
W ,H
1
2
(‖X − WH‖2F + λ‖(L + I)H‖1)
(5)
The objective function consists of 2 terms. The first
termminimizes the difference between the input matrix X
and its factorization, WH, based on the Frobenius norm.
The second term is an L1-regularization term, which
consists of 2 components. The first component, LH, pro-
motes piece-wise smoothness on the tissue abundance
maps. L is a sparse n×n matrix, with each row contain-
ing a vectorized Laplacian kernel. As such, each row of L
applies a two-dimensional second order spatial derivative
to the corresponding voxel. An in-plane neighborhood
of 4 voxels is considered for the Laplacian kernel. Due
to the relatively low out-of-plane resolution of the MRI
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data, neighboring voxels in adjacent slices are not consid-
ered. The second component applies L1-regularization to
H directly, imposing sparseness to the abundance maps.
The above NMF formulation [39] is solved using the
structured data fusion framework [40] as implemented in
Tensorlab [41]. A transformation of variables is used to
convert the constrained optimization problem in Eq. 5
into an unconstrained problem, by squaring the entries
of the factor matrices. The Gauss-Newton algorithm with
dogleg trust region (GNDL) is used to solve the resulting
non-linear least-squares problem [42]. At each iteration
of the GNDL algorithm, a step is calculated by itera-
tively solving a linearized version of Eq. 5 using conjugate
gradients. A maximum number of 500 iterations and a
convergence tolerance of 10−6 for the relative difference of
two subsequent values of the objective function were used
as stopping criteria for the NMF analyses. The regulariza-
tion coefficient λ was empirically set to 0.1, after testing a
range of λ values and refining the search near λ = 0.1.
NMF initialization
As NMF poses a non-convex optimization problem, ini-
tialization of the factor matrices (W0 and H0) is required.
Careful initialization is important, as it might speed up
the convergence process and influence the final segmen-
tation result. The pathological tissue sources are initial-
ized based on voxel selection. The user is required to
select one or more voxels in each pathological region, i.e.
active tumor and, if present, necrosis and edema. For each
selected voxel, a candidate source vector is added to W0
as the averaged feature vector of the selected voxel and
its 4 in-plane neighboring voxels. For each pathological
tissue class, we then calculate the correlation coefficient
between the candidate source vectors as their inner vec-
tor product after normalization. The initial pathological
sources are obtained after merging candidate source vec-
tors with a correlation coefficient higher than 0.95 in W0
and replacing them by their average, thereby reducing
complexity of the NMF model.
As the normal brain tissue types (i.e. white matter, grey
matter, cerebro-spinal fluid and blood vessels) are still
highly abundant in the affected brain, an automated seed-
ing procedure is used to obtain their initial source vectors.
To cope with the variance within the tissue classes, 2
sources are assigned to each normal tissue type, leading
to a total of 8 normal tissue sources. We use the Succes-
sive projection algorithm (SPA) [43] to obtain an initial
estimate of the normal sources. SPA returns a subset of
voxels from the input matrix X with minimal collinearity
in feature space. All columns of X are first projected onto
the orthogonal subspace of the already initialized patho-
logical sources. A first normal seeding point is selected
as the voxel with the highest L2-norm in the orthogo-
nal subspace. All columns are then further projected onto
the orthogonal subspace of the added voxel, and the next
seeding point is selected as the point with the highest
L2-norm among these projected columns. The above pro-
cedure is repeated until 8 voxels (for initializing the 8
normal tissue sources) have been selected. Similarly to the
pathological sources, the normal sources are obtained as
the averaged feature vector of each selected voxel and its
4 in-plane neighboring voxels, assuming these to belong
to the same tissue type as the selected voxel. As SPA is
known to be sensitive to outliers [44], an additional FCM
procedure is applied, using the initial pathological sources
and the normal sources obtained from SPA to initialize
the cluster centroids. FCM alternatingly updates the clus-
ter centroids and the cluster membership values. As we
already obtained proper initialization of the pathological
tissue types through user input, the pathological cluster
centroids are forced to remain the same throughout the
FCM updating procedure. The final FCM centroids make
up the columns of W0. The columns of H0 are found by
applying non-negative least squares fitting to the corre-
sponding column of X and W0. To reduce computation
time, a downsampling factor of 2 was applied to the x-
and y-direction of each image slice. After NMF analy-
sis, the obtained tissue abundance maps were upsampled
again through linear interpolation. Performance was not
affected by this downsampling procedure.
Morphological post-processing
After NMF analysis, each voxel is assigned to the source
for which it has the highest abundance value. Voxels
that were assigned to different sources belonging to the
same pathological tissue class are merged to obtain a
preliminary tissue segmentation mask. A morphological
post-processing procedure, consisting of 2 steps is then
applied to the pathological segmentation masks to further
remove false positives, by exploiting the known location
of the user-selected voxels. Spatial consistency of the tis-
sue regions is assumed, therefore the segmentation masks
are analyzed in terms of (3D-)connected components.
For each selected pathological tissue type, only the con-
nected component closest to each user-defined voxel is
withheld in the corresponding tissue segmentation mask
(Step 1). As the user-defined voxels are not necessar-
ily selected close to the centre of the tissue region, the
distance between a selected voxel and a connected com-
ponent is defined as the minimal distance between the
selected voxel and any voxel from the connected compo-
nent. It is possible that the same connected component is
found for several or all user-selected voxels of the same
tissue class.
To avoid missing disjoint regions of a tumor compo-
nent for which no voxels were selected by the user, an
additional step is performed which assumes spatial con-
nectivity of the various pathological components (Step
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2). For instance, necrotic areas are always adjacent to
an active tumor region. Therefore, any connected com-
ponent of the preliminary necrosis mask which has a
common edge with any withheld active tumor component
is also included. Similarly, components of the preliminary
active tumor mask are also included if they have a com-
mon edge with any withheld necrotic component. The
same procedure is also applied to edema, by verifying
spatial adjacency to the active tumor region(s). Figure 1
illustrates the morphological post-processing procedure
for the necrotic tissue mask. One small necrotic compo-
nent is not withheld after Step 1, as the user didn’t click
in this region. However, it was still recovered in Step 2 by
verifying spatial connectivity with the active tumor mask.
Validation
Segmentation results of the pathological tissue regions
were compared against manual segmentation by an expe-
rienced radiologist. The Dice-score was used to quantify
the spatial alignment between semi-automated and man-
ual segmentation:
Dicetissue = 2 × Atissue,NMF ∩ Atissue,manAtissue,NMF + Atissue,man (6)
where Atissue,NMF is the area segmented by NMF and
Atissue,man the area manually segmented by the radiologist
for the same tissue type. Additionally, the Hausdorff dis-
tance was calculated for evaluating the distance between
segmentation boundaries. The Hausdorff distance is the
maximum distance of all points from one segmentation
mask to the corresponding nearest point of the other
segmentation mask:
Haustissue = max
(
sup
p∈Atissue,NMF
inf
t∈Atissue,man
d(p, t), sup
t∈Atissue,man
inf
p∈Atissue,NMF
d(t, p)
)
(7)
where sup and inf represent the supremum and infinum,
respectively. d(p, t) is a distance metric, for which the
Euclidean distance is commonly used. The Hausdorff dis-
tance is however susceptible to small outlying subregions
in either segmentation masks, as it considers the maxi-
mum surface distance. To overcome this limitation, we
considered a more robust version of the Hausdorff mea-
sure, reporting the 95-percentile instead of the maximum
surface distance. In analogy to previous work [14], Dice-
scores and Hausdorff distances are reported for active
tumor, the tumor core (active tumor + necrosis) and the
whole tumor (tumor core + edema). To verify robustness
of the semi-automated method to user input variabil-
ity, the NMF analysis was repeated 20 times per patient
with different selection of the seeding points. In each
run, an automatic random selection of 3 points was per-
formed in each pathological region, based on the manual
segmentation masks.
Besides NMF with spatial regularization and sparse-
ness (NMFspatial_sparse), additional NMF analyses were
performed to assess the added value of the regulariza-
tion term and the advanced MRI modalities: NMF with-
out regularization (NMFno_reg), NMF with only spatial
regularization (NMFspatial), NMF with spatial regulariza-
tion and sparseness but without the morphological post-
processing step (NMFno_postproc), and NMF with spatial
regularization and sparseness when only considering
Fig. 1 Illustration of morphological post-processing after initial semi-automated NMF based segmentation of necrosis a and active tumor c. Step 1:
false positives are removed by withholding only the connected components closest to the user-defined seeding points (marked by cursor arrows)
for necrosis (b) and for active tumor (d). Step 2: spatial adjacency of the connected components in the preliminary necrosis mask (green) to the
withheld active tumor mask (red) is verified in (e). The final necrosis mask is shown in yellow in (f)
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cMRI data (NMFcMRI). For the NMFcMRI analyses, rCBV
and ADC were omitted from the MP-MRI feature set but
b0 was withheld, acting as a surrogate for T2-weighted
MRI.
Results
Figure 2 gives an example of the regularized NMF results
and tissue segmentation for a GBM patient with a typical
ring-enhancing lesion. Some of the MP-MRI input maps
are shown on the first row. The NMF abundance maps
as well as the final segmentation masks are shown for the
pathological tissue types on the second row.
Figure 3 gives a comparison of the segmented patho-
logical regions for a GBM patient obtained from the dif-
ferent NMF analyses (NMFno_reg, NMFspatial, NMFcMRI
and NMFspatial_sparse) and manual segmentation. For the
active tumor region, spatial overlap with manual segmen-
tation is slightly lower for NMFspatial compared to the
other methods. On the other hand, the spatial regular-
ization term did allow NMFspatial to segment the entire
necrotic region, whereas the other methods missed a cen-
tral portion of the necrotic area. Segmentation of edema
is inferior for NMFcMRI, where the differentiation from
surrounding healthy brain structures was found difficult.
NMFspatial_sparse shows the least false positive regions for
necrosis and edema compared to the other methods.
Figure 4 shows the dispersion of the Dice-scores for
active tumor per patient over 20 runs. Sixteen out of 21
patients have a median Dice-score of at least 60%. Fifteen
patients have a lower quartile Dice-score of at least 50%.
Seventeen patients have an interquartile range not higher
than 15%. Seven patients had at least one run with a Dice-
score lower than 30%. A large spread in the Dice-scores
is seen for patient 6, who has a non-enhancing anaplastic
astrocytoma with focal areas of enhancing GBM. Variabil-
ity in the results was caused by the difficult differentiation
of non-enhancing tumor from edema. Patient 8 suffers
from a non-enhancing bifocal GBM, with only a small
enhancing area in the smaller lesion. Due to the random
selection of voxels in the active tumor region, in some
runs voxels were only selected from one of both lesions,
resulting in a failure to detect the other lesion. A large
dispersion in the Dice-scores is also found for patient 18,
exhibiting a heterogeneous and irregularly shaped GBM
with varying degrees of enhancement in the active tumor
region. Active tumor and necrosis were not well differ-
entiated in some runs, mainly due to ambiguous voxel
selection near the pathological tissue boundaries. The low
outlier scores for patient 10 are due to the difficult differ-
entiation of non-enhancing tumor from edema. The low
outlier score for patient 13 is explained by a suboptimal
and unrepresentative random voxel selection in the active
tumor region.
Boxplots for the tumor core are shown in Fig. 5. Eigh-
teen out of 21 patients have a median Dice-score higher
than 65%. For 17 patients, the lower quartile Dice-score
was at least 60%. The interquartile range was not higher
than 15% for 17 patients. Seven patients have at least one
run with a Dice-score lower than 40%. For 5 out of the 7
patients, these low Dice-scores were found to be outliers
(i.e. at a distance of more than 1.5 times the interquartile
range from the lower quartile value).
Figure 6 shows the boxplots for the whole tumor region.
A median Dice-score higher than 70% was found for 19
out of 21 patients. Eighteen patients have lower quartile
value higher than 60%. Five patients have at least one run
with a Dice-score lower than 45%. For 4 out of these 5
patients, such low values were found to be outliers.
Fig. 2 First row: coregistered MP-MRI maps of a GBM patient, left to right: T1C, FLAIR, rCBV, ADC. Second row, left to right: NMF abundance maps for
active tumor, necrosis and edema. The final segmentation masks are shown on the right for active tumor (red), necrosis (yellow) and edema (blue)
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Fig. 3 Comparison of the segmentation results of the pathological tissue regions obtained for a GBM patient using the different NMFmethodologies.
The left figure of each row shows the obtained segmentation for active tumor (purple), necrosis (red) and edema (yellow). The second to fourth figure
of each row show the individual segmentation for active tumor, necrosis and edema, respectively. The top row shows manual segmentation,
whereas the other rows show the overlap between the NMF (blue) and manual (green) segmentation result. Segmentation overlap is marked in cyan
Table 2 gives a comparison of themean Dice-scores over
all patients for the different NMF analyses. Overall, the
best performance is obtained withNMFspatial_sparse.When
considering only spatial regularization (NMFspatial), seg-
mentation results are mainly worse for the active tumor
region, where the Dice-scores are even lower than for
NMFno_reg. The spatial smoothing was found to be too
severe for several GBMs with a narrow ring-enhancing
active tumor compartment. Compared to NMFno_reg,
Dice-scores are higher with NMFspatial_sparse for active
tumor and the tumor core, with an increase of 2%
in most cases. The Dice-score for the whole tumor
region is 0 to 1% higher for NMFspatial_sparse com-
pared to NMFno_reg. NMFspatial_sparse does not show any
improvement compared toNMFcMRI for the active tumor
region. An increase in Dice-score of 1 to 2% is found
for the tumor core and an increase of 3 to 4% for the
whole tumor region. The lowest Dice-scores are found for
NMFno_postproc, with a decrease of 6 to 8% compared to
NMFspatial_sparse.
Table 3 reports the mean Hausdorff distances over all
the patients for the different NMF analyses. The low-
est Hausdorff distances are found for NMFspatial_sparse,
with mean values of 6.1 mm, 7.4 mm and 8.2 mm for
active tumor, the tumor core and the whole tumor region,
respectively. Comparable but slightly higher Hausdorff
distances are found forNMFno_reg andNMFspatial. Higher
Hausdorff distances are found for NMFcMRI, with mean
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Fig. 4 Boxplots showing the dispersion of the Dice-scores for active tumor. Boxplots show quartile ranges of the Dice-scores, ’+’ indicates outliers
values of 7.4 mm, 9.1 mm and 14.1 mm. Hausdorff dis-
tances increase considerably when morphological post-
processing is omitted: mean values of 26.6 mm, 29.3 mm
and 28.9 mm are found for NMFno_postproc.
Discussion
Comparison to other segmentation studies is sometimes
hampered by the fact that different segmentation met-
rics or a different definition of the pathological subregions
are being considered. We have quantified our results for
active tumor, the tumor core and the whole tumor region
using the Dice-score, in accordance with the Multimodal
Brain Tumor Segmentation (BRATS) challenge held at
the Medical Image Computing and Computer Assisted
Intervention (MICCAI) conference. Looking at the Dice-
scores reported for HGGs on the BRATS 2012 and 2013
datasets [14], it can be seen that our results are compet-
itive, even when looking at the mean of 25th percentile
values (see Table 2). For the whole tumor region, Dice-
scores are close to or even higher than 80%, which is
in the range of inter-observer variability [14]. We have
also applied semi-automated L1-regularizedNMF directly
to the BRATS 2013 Leaderboard dataset, allowing for a
direct comparison with state-of-the-art [45]. It was found
Fig. 5 Boxplots showing the dispersion of the Dice-scores for the tumor core. Boxplots show quartile ranges of the Dice-scores, ’+’ indicates outliers
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Fig. 6 Boxplots showing the dispersion of the Dice-scores for the whole tumor region. Boxplots show quartile ranges of the Dice-scores, ‘+’
indicates outliers
that our segmentation framework outperformed all other
methods in segmenting the active tumor region, and
was also competitive for the tumor core and the whole
tumor region. As the BRATS dataset only contains cMRI
data, comparison is most appropriate to the NMFcMRI
results. The inclusion of additional MRI modalities for
brain tumor segmentation has been commonly suggested
[2, 46] and initial studies have found improved segmen-
tation results with extended MP-MRI datasets [28, 47].
When including ADC and rCBV into the MRI feature
set, we found no advantage for the active tumor region,
but Dice-scores increased by 1 to 2% for the tumor core
and by 3 to 4% for the whole tumor region. These find-
ings are in accordance with [28], where inclusion of PWI
and DWI were found to be mainly advantageous for the
tumor core and the whole tumor region. Segmentation
performance was also assessed using the Hausdorff dis-
tance (see Table 3). As for the Dice-score, we obtained
mean Hausdorff distances which are competitive with the
best methods reported on the BRATS 2012 and 2013
datasets [14]. Another important consideration of any seg-
mentation algorithm is its computational cost. To reduce
computation time, we have applied downsampling to the
in-plane dimensions of the imaging data. A downsampling
factor of 2 was found not to affect segmentation perfor-
mance. In the case of isotropic imaging data, where the
out-of-plane resolution is as high as the in-plane resolu-
tion, downsampling could be applied to all 3 dimensions,
with no expected loss in segmentation performance.
Most of the unsupervised brain tumor segmentation
algorithms in literature incorporate prior knowledge in
the form of basic assumptions or heuristics, which often
limits their general applicability to a subset of gliomas
or to a particular set of MP-MRI data. Prior knowledge
in the form of user input is flexible, allowing to incor-
porate patient-specific information regarding appearance,
Table 2 Mean Dice-scores [%] for NMF without regularization, with spatial regularization, with spatial and sparse regularization but
without morphological post-processing, with spatial and sparse regularization on the cMRI data only, and with spatial and sparse
regularization on the full MP-MRI dataset
Active tumor [%] Tumor core [%] Whole tumor [%]
25th prcntile Mean 75th prcntile 25th prcntile Mean 75th prcntile 25th prcntile Mean 75th prcntile
NMFno_reg 58 63 72 66 72 79 76 80 84
NMFspatial 55 60 70 65 71 79 76 80 85
NMFno_postproc 54 59 67 62 68 73 71 73 77
NMFcMRI 60 65 74 67 72 79 73 77 82
NMFspatial_sparse 60 65 74 68 74 80 77 80 85
For each tissue class, the first column reports the mean of the 25th percentile Dice-score across all patients, the second column the mean of the mean Dice-score across all
patients and the third column the mean of the 75th percentile Dice-score
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Table 3 Mean Hausdorff distances [mm] for NMF without regularization, with spatial regularization, with spatial and sparse
regularization but without morphological post-processing, with spatial and sparse regularization on the cMRI data only, and with
spatial and sparse regularization on the full MP-MRI dataset
Active tumor [mm] Tumor core [mm] Whole tumor [mm]
25th prcntile Mean 75th prcntile 25th prcntile Mean 75th prcntile 25th prcntile Mean 75th prcntile
NMFno_reg 3.3 6.9 8.1 3.1 7.9 9.7 3.8 8.6 10.6
NMFspatial 3.7 7.1 8.2 3.2 7.9 9.5 3.3 8.4 10.4
NMFno_postproc 21.4 26.6 33.2 24.5 29.3 35.6 23.8 28.9 33.7
NMFcMRI 4.2 7.4 8.2 5.6 9.1 10.5 5.2 14.1 17.9
NMFspatial_sparse 2.7 6.1 6.7 2.7 7.4 9.2 3.1 8.2 10.1
For each tissue class, the first column reports the mean of the 25th percentile Hausdorff distance across all patients, the second column the mean of the mean Hausdorff
distance across all patients and the third column the mean of the 75th percentile Hausdorff distance
location and/or shape of the tumor. Using our semi-
automated framework, we were able to tackle the main
limitations of many unsupervised classification methods
like NMF. Most unsupervised algorithms require proper
initialization to come to a valid locally optimal solution.
Several studies cope with this by running the segmenta-
tion algorithm numerous times with a randomized ini-
tialization, then selecting the final solution based on a
predefined objective function [24, 28]. We are combining
user-defined voxel selection for initializing the patho-
logical sources with a sophisticated initialization of the
normal brain tissue sources based on SPA and FCM. As
SPA is sensitive to outliers, its output is fed into the FCM
algorithm, thereby providing a deterministic initialization
for FCM.
Due to the lack of labelled training data, automatic
assignment of a tissue label to each segmented region
is non-trivial for unsupervised methods. Several studies
do not explicitly propose an automated labelling strategy
[25, 27], while others assume specific characteristics of
the tumor compartments in specific MRI images (such
as e.g. contrast enhancement of active tumor) [22, 23].
In our proposed methodology, tissue labelling automati-
cally results from the voxel selection in the pathological
regions.
False positive regions were excluded from the patholog-
ical tissue masks by exploiting the spatial location of the
selected voxels in a morphological post-processing pro-
cedure. As the pathological tissue classes are assumed
to form spatially consistent regions, only the connected
component closest to each selected voxel is withheld
in the segmentation masks. Loss of tumor components
not selected by the user is avoided by assuming spatial
adjacency of the pathological regions. Mean Dice-scores
decreased by 6 to 8% when omitting the morpholog-
ical post-processing step after NMF with spatial regu-
larization and sparseness (Table 2, NMFno_postproc). Loss
in performance was more pronounced when consider-
ing the Hausdorff distance, with mean values being an
order of magnitude larger for NMFno_postproc than for
the other NMF analyses (Table 3). This indicates that
our semi-supervised approach allows for the removal of
false positive regions at considerable distance from the
actual tumor volume, by exploiting the spatial location
of the user-defined seeding points. Similar types of post-
processing have been proposed to enhance segmentation
results. Cordier et al. only withheld 1 or 2 connected
components for each tissue region based on their size,
assuming that the largest component(s) correspond to the
true tissue region [32]. Menze et al. exploit knowledge
about shape and location of the tumor based on an atlas
tissue prior to remove false positives [25]. Havaei et al.
initialize a k-nearest neighbors (kNN) classifier based on
voxel selection by the user [35]. They do not exploit the
spatial location of the selected voxels in a post-processing
step, but instead they add voxel coordinates to the feature
set of the kNN classifier.
Nowadays, a common approach to further improve seg-
mentation results is to model the spatial dependency
between the tissue labels of adjacent voxels, typically using
a Markov Random Field (MRF) [25, 35] or a Condi-
tional Random Field (CRF) [15, 17]. With MRF, a fixed
penalty term is added to the cost function when adja-
cent voxels have different labels. This penalty term is
also depending on the (dis)similarity of the feature vec-
tors when using CRF. To the authors’ knowledge, this
is the first study to consider spatially regularized NMF
for tumor segmentation. We have added a spatial reg-
ularization term with sparseness to the NMF objective
function. L1-regularization was used to promote piece-
wise smoothness of the abundance maps, allowing for
discontinuities at the tissue boundaries. Whereas MRF
and CRF are directly applied to the voxel labels, we applied
L1-regularization to the tissue abundance maps which
represent continuous variables. In some patients, subop-
timal segmentation results were found when using spatial
regularization only. This is reflected in the lower Dice-
scores for NMFspatial in the active tumor region and in
the tumor core region (Table 2). The original abundance
maps have a relatively low degree of sparseness, such that
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piece-wise spatial smoothness was not always restricted
to the true tissue boundaries. Results were improved by
combining spatial regularization with sparseness. This
kind of regularization resembles MRF more closely, since
MRF implies absolute sparseness of the tissue labels. Over
all patients, we found an increase in mean Dice-score by
2% for active tumor and for the tumor core when using
spatial regularization with sparseness (Table 2). For the
whole tumor region, an increase of 1% was found for
the 25th and 75th percentile Dice-scores and no increase
was found for the mean value. Similar improvements in
segmentation results have been reported in the literature
[17, 35].
As imaging characteristics vary considerably across
glioma subtypes and grades, supervised classification
methods require extensive training datasets with a uni-
form acquisition protocol. To increase specificity, sepa-
rate classifiers are usually built for low- and high-grade
gliomas [14]. Using training data from different patients
to segment a new test case requires careful calibration of
image intensities across different patients, which is non-
trivial in the presence of pathology. Our method uses
labelled data only from the patient under study. Fea-
ture vectors averaged over the local neighborhood of the
selected voxels are assumed to be approximative proto-
types of the pathological tissue regions to be segmented.
One of the main limitations of any semi-automated
segmentation algorithm is that they don’t provide repro-
ducible results. Robustness against user input variability
is therefore a key aspect. We have assessed user input
variability by repeatedly selecting random voxels in each
pathological region. Fairly robust segmentation results
were found for most patients (see Figs. 4, 5 and 6), but
a large spread in the Dice-scores and low outlier values
were found in several patients as well. In some cases sub-
optimal results could be explained by ambiguous voxel
selection near the tissue boundaries. Figure 7 illustrates
a case of suboptimal voxel selection for patient 1. One of
the necrotic voxels was selected at the edge of the man-
ually segmented necrotic region (red voxel in B, other
necrotic voxels were selected on other slices). This voxel
is located very near the active tumor region and does not
show the hypo-intense T1C signal which is characteristic
for necrosis. The resulting NMF segmentation is shown
in C for active tumor and in D for necrosis. The necrotic
voxel selected at the boundary results in an overestima-
tion of the necrotic region and an underestimation of the
tumor region. The low outlier Dice-score for patient 1 for
active tumor in Fig. 4 corresponds to this voxel selection.
Another patient had a bi-focal tumor, and in some runs
only one of both lesions was detected as no voxels were
selected in the other lesion. Random voxel selection from
the manually segmented tumor subregions might not be
entirely representative for the user input variability that is
to be be expected from trained radiologists. It might be
more effective to consider actual user input from various
experts in a future study. Valid segmentation results can
only be obtained when seeding points are selected in an
intelligible way. Spatially distributing the selected voxels
is one way of covering intra-tissue heterogeneity. Seed-
ing points should be selected in each lesion in order to
properly detect multi-focal tumors. Careful voxel selec-
tion is expected to further improve segmentation results
and reduce variability.
Fig. 7 Example of a bad segmentation result due to suboptimal voxel selection. A close-up of a GBM lesion on an axial T1C slice (a). The manually
segmented necrotic region is shown in yellow (b), the selected necrotic voxel is marked in red. Segmentation of the active tumor region (c) and
necrotic region (d) on several slices, blue indicates NMF segmentation, green indicates manual segmentation and cyan indicates overlap
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Conclusion
We have presented a semi-automated brain tumor seg-
mentation method, based on NMF with L1-regularization
to promote spatial consistency and sparseness of the tissue
abundance maps. The semi-automated framework was
applied to an MP-MRI dataset consisting of cMRI, PWI
and DWI. User-defined voxel selection is applied to ini-
tialize pathological sources of the NMF analysis, and to
exploit knowledge about the spatial location of the tumor
to remove false positives in a post-processing step. In this
way, we aimed at incorporating prior knowledge while
maintaining general applicability of our method to any
type of glioma and to any MP-MRI dataset. Sensitivity to
user input variability was explored through repeated anal-
yses with different voxel selection. Robust results were
found for most patients, although careful voxel selection is
mandatory to avoid sub-optimal segmentation. Based on
the reported mean Dice-scores and Hausdorff distances,
segmentation results are competitive with state-of-the-art
in literature.
Abbreviations
ADC: Apparent diffusion coefficient; BRATS: Multimodal Brain Tumor
Segmentation challenge; cMRI: Conventional MRI; CRF: Conditional random
field; DWI: Diffusion-weighted imaging; FCM: Fuzzy C-means clustering; FLAIR:
Fluid-attenuated inversion recovery; GBM: Glioblastoma multiforme; GNDL:
Gauss-Newton with dogleg trust region; HGG: High-grade glioma; kNN:
k-nearest neighbors; MP-MRI: Multi-parametric MRI; MRF: Markov random field;
NMF: Non-negative matrix factorization; PWI: Perfusion-weighted imaging;
RANO: Response assessment in neuro-oncology; rCBV: Relative cerebral blood
volume; SPA: Successive projection algorithm; T1C: T1-imaging with contrast
enhancement; TE: Echo time; TI: Inversion time; TR: Repetition time
Acknowledgments
Not applicable.
Funding
NS, DMS and MA received funding from the Research Foundation Flanders
(FWO), grant number G.0869.12N. JV received funding from the Henri
Benedictus Fellowship of the Belgian American Educational Foundation. SVH
received funding from the government agency for Innovation by Science and
Technology (IWT), grant number IM 135005. SVH received funding from the
European Research Council under the European Union’s Seventh Framework
Programme, grant number 339804. SVH and DMS received funding from the
European Research Council under the European Union’s Seventh Framework
Programme, grant number 316679. The funders had no role in study design,
data collection and analysis, decision to publish, or preparation of the
manuscript.
Availability of data andmaterials
The datasets analysed during the current study are not publicly available due
to them containing information that could compromise research participant
privacy/consent. The data are available from the corresponding author on
reasonable request.
Authors’ contributions
EA and MA acquired and anonymized the patient imaging data. JV provided
software code and advice to pre-process the DWI data. NS and DMS designed
the semi-automated segmentation framework. NMF analyses were performed
by NS. The study was supervised by SVH and EA. NS, DMS, SVH, FM and UH
were major contributors in writing the manuscript. All authors read and
approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
Written informed consent was not obtained from all patients for their data to
be used in the current study. The need for consent was waived by the local
ethics committee of the University Hospital Ghent due to the retrospective
nature of the analyses. All patient data were fully anonymized at their native
institution prior to access.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Department of Electrical Engineering (ESAT), STADIUS Centre for Dynamical
Systems, Signal Processing and Data Analytics, KULeuven, Kasteelpark
Arenberg, Leuven, Belgium. 2imec, Kapeldreef 75, 3001 Leuven, Belgium.
3Department of Radiology, Ghent University Hospital, De Pintelaan 185, 9000
Ghent, Belgium. 4Department of Physics, iMinds Vision Lab, University of
Antwerp, Edegemsesteenweg 200–240, 2610 Antwerp, Belgium. 5Department
of Electrical Engineering (ESAT), PSI Centre for Processing Speech and Images,
KULeuven, Kasteelpark Arenberg 10, 3001 Leuven, Belgium. 6Department of
Imaging and Pathology, Biomedical MRI/MoSAIC, KULeuven, Herestraat 49,
3000 Leuven, Belgium.
Received: 21 September 2016 Accepted: 11 April 2017
References
1. Ostrom QT, Gittleman H, Liao P, Rouse C, Chen Y, Dowling J, Wolinsky Y,
Kruchko C, Barnholtz-Sloan J. CBTRUS statistical report: primary brain and
central nervous system tumors diagnosed in the United States in
2007–2011. Neuro-oncology. 2014;16(suppl 4):1–63.
2. Cha S. Update on brain tumor imaging: from anatomy to physiology. Am
J Neuroradiol. 2006;27(3):475–87.
3. Young GS. Advanced MRI of adult brain tumors. Neurol Clin. 2007;25(4):
947–73.
4. Van Cauter S, De Keyzer F, Sima DM, Sava AC, D’Arco F, Veraart J,
Peeters RR, Leemans A, Van Gool S, Wilms G, et al. Integrating diffusion
kurtosis imaging, dynamic susceptibility-weighted contrast-enhanced
MRI, and short echo time chemical shift imaging for grading gliomas.
Neuro-oncology. 2014;16(7):1010–21.
5. Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D. Intracranial
mass lesions: Dynamic contrast-enhanced susceptibility-weighted
echo-planar perfusion MR imaging 1. Radiology. 2002;223(1):11–29.
6. Bulakbasi N, Kocaoglu M, Farzaliyev A, Tayfun C, Ucoz T, Somuncu I.
Assessment of diagnostic accuracy of perfusion MR imaging in primary
and metastatic solitary malignant brain tumors. Am J Neuroradiol.
2005;26(9):2187–199.
7. Hu LS, Eschbacher JM, Heiserman JE, Dueck AC, Shapiro WR, Liu S,
Karis JP, Smith KA, Coons SW, Nakaji P, et al. Reevaluating the imaging
definition of tumor progression: perfusion MRI quantifies recurrent
glioblastoma tumor fraction, pseudoprogression, and radiation necrosis
to predict survival. Neuro-Oncology. 2012;14(7):919–30.
8. Price S, Jena R, Burnet N, Hutchinson P, Dean A, Pena A, Pickard J,
Carpenter T, Gillard J. Improved delineation of glioma margins and
regions of infiltration with the use of diffusion tensor imaging: an
image-guided biopsy study. Am J Neuroradiol. 2006;27(9):1969–74.
9. Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG,
Galanis E, DeGroot J, Wick W, Gilbert MR, Lassman AB, et al. Updated
response assessment criteria for high-grade gliomas: response assessment
in neuro-oncology working group. J Clin Oncol. 2010;28(11):1963–72.
10. Dhermain F. Radiotherapy of high-grade gliomas: current standards and
new concepts, innovations in imaging and radiotherapy, and new
therapeutic approaches. Chin J Cancer. 2014;33(1):16–24.
11. Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F,
Lang FF, McCutcheon IE, Hassenbusch SJ, Holland E, Hess K, Michael C,
Miller D, Sawaya R. A multivariate analysis of 416 patients with
glioblastoma multiforme: prognosis, extent of resection, and survival.
J Neurosurg. 2001;95(2):190–8.
Sauwen et al. BMCMedical Imaging  (2017) 17:29 Page 14 of 14
12. Ellingson BM, Cloughesy TF, Lai A, Nghiemphu PL, Mischel PS, Pope WB.
Quantitative volumetric analysis of conventional MRI response in
recurrent glioblastoma treated with bevacizumab. Neuro-oncol.
2011;13(4):206.
13. Gordillo N, Montseny E, Sobrevilla P. State of the art survey on MRI brain
tumor segmentation. Magn Reson Imaging. 2013;31(8):1426–38.
14. Menze B, Reyes M, Van Leemput K, et al. The multimodal brain tumor
image segmentation benchmark (BRATS). IEEE Trans Med Imaging.
2015;34(10):1993–2024.
15. Bauer S, Fejes T, Slotboom J, Wiest R, Nolte LP, Reyes M. Segmentation
of brain tumor images based on integrated hierarchical classification and
regularization. In: International Conference on Medical Image Computing
and Computer-Assisted Intervention. Berlin: Springer; 2012. p. 10–13.
16. Zikic D, Glocker B, Konukoglu E, Criminisi A, Demiralp C, Shotton J,
Thomas O, Das T, Jena R, Price S. Decision forests for tissue-specific
segmentation of high-grade gliomas inmulti-channel MR. In: International
Conference on Medical Image Computing and Computer-Assisted
Intervention, vol. LCNS 7512. Berlin: Springer; 2012. p. 369–76.
17. Lee CH, Wang S, Murtha A, Brown MR, Greiner R. Segmenting brain
tumors using pseudo–conditional random fields. In: International
Conference on Medical Image Computing and Computer-Assisted
Intervention. Berlin: Springer; 2008. p. 359–66.
18. Verma R, Zacharaki EI, Ou Y, Cai H, Chawla S, Lee SK, Melhem ER, Wolf R,
Davatzikos C. Multiparametric tissue characterization of brain neoplasms
and their recurrence using pattern classification of MR images. Acad
Radiol. 2008;15(8):966–77.
19. Jensen TR, Schmainda KM. Computer-aided detection of brain tumor
invasion using multiparametric MRI. J Magn Reson Imaging. 2009;30(3):
481–9.
20. Li SZ. Markov random field modeling in image analysis: Springer; 2009.
ISBN: 1848002793.
21. Lafferty J, McCallum A, Pereira F. Conditional random fields: Probabilistic
models for segmenting and labeling sequence data. In: Proceedings of
the Eighteenth International Conference on Machine Learning, ICML,
vol. 1. Williamstown; 2001. p. 282–9.
22. Fletcher-Heath LM, Hall LO, Goldgof DB, Murtagh FR. Automatic
segmentation of non-enhancing brain tumors in magnetic resonance
images. Artif Intell Med. 2001;21(1):43–63.
23. Kazerooni AF, Mohseni M, Rezaei S, Bakhshandehpour G, Rad HS.
Multi-parametric (ADC/PWI/T2-w) image fusion approach for accurate
semi-automatic segmentation of tumorous regions in glioblastoma
multiforme. Magn Reson Mater Phys Biol Med. 2015;28(1):13–22.
24. Juan-Albarracín J, Fuster-Garcia E, Manjón JV, Robles M, Aparici F,
Martí-Bonmatí L, García-Gómez JM. Automated glioblastoma
segmentation based on a multiparametric structured unsupervised
classification. PloS One. 2015;10(5):0125143.
25. Menze BH, Van Leemput K, Lashkari D, Weber MA, Ayache N, Golland P.
A generative model for brain tumor segmentation in multi-modal
images. In: International Conference on Medical Image Computing and
Computer-Assisted Intervention, vol. 13. Berlin: Springer; 2010. p. 151–9.
26. Zhang Y, Brady M, Smith S. Segmentation of brain MR images through a
hidden markov random field model and the expectation-maximization
algorithm. IEEE Trans Med Imaging. 2001;20(1):45–57.
27. Nie J, Xue Z, Liu T, Young GS, Setayesh K, Guo L, Wong ST. Automated
brain tumor segmentation using spatial accuracy-weighted hidden
markov random field. Comput Med Imaging Graph. 2009;33(6):
431–41.
28. Sauwen N, Sima DM, Van Cauter S, Veraart J, Leemans A, Maes F,
Himmelreich U, Van Huffel S. Hierarchical non-negative matrix
factorization to characterize brain tumor heterogeneity using
multi-parametric MRI. NMR Biomed. 2015;28(12):1599–624.
29. Ortega-Martorell S, Lisboa PJ, Vellido A, Simões RV, Pumarola M,
Julià-Sapé M, Arús C. Convex non-negative matrix factorization for brain
tumor delimitation from MRSI data. PloS One. 2012;7(10):47824.
30. Prastawa M, Bullitt E, Moon N, Van Leemput K, Gerig G. Automatic brain
tumor segmentation by subject specific modification of atlas priors 1.
Acad Radiol. 2003;10(12):1341–8.
31. Saha BN, Ray N, Greiner R, Murtha A, Zhang H. Quick detection of brain
tumors and edemas: A bounding box method using symmetry. Comput
Med Imaging Graph. 2012;36(2):95–107.
32. Cordier N, Menze B, Delingette H, Ayache N. Patch-based segmentation
of brain tissues. In: International Conference onMedical Image Computing
and Computer-Assisted Intervention. Berlin: Springer; 2013. p. 6–17.
33. Kwon D, Shinohara RT, Akbari H, Davatzikos C. Combining generative
models for multifocal glioma segmentation and registration. In:
International Conference on Medical Image Computing and
Computer-Assisted Intervention. Berlin: Springer; 2014. p. 763–70.
34. Hamamci A, Kucuk N, Karaman K, Engin K, Unal G. Tumor-cut:
segmentation of brain tumors on contrast enhanced MR images for
radiosurgery applications. IEEE Trans Med Imaging. 2012;31(3):790–804.
35. Havaei M, Jodoin PM, Larochelle H. Efficient interactive brain tumor
segmentation as within-brain kNN classification. In: ICPR. Stockholm;
2014. p. 556–61.
36. Boxerman J, Schmainda K, Weisskoff R. Relative cerebral blood volume
maps corrected for contrast agent extravasation significantly correlate
with glioma tumor grade, whereas uncorrected maps do not. Am J
Neuroradiol. 2006;27(4):859–67.
37. Veraart J, Sijbers J, Sunaert S, Leemans A, Jeurissen B. Weighted linear
least squares estimation of diffusion MRI parameters: strengths,
limitations, and pitfalls. NeuroImage. 2013;81:335–46.
38. Maes F, Collignon A, Vandermeulen D, Marchal G, Suetens P.
Multimodality image registration by maximization of mutual information.
IEEE Trans Med Imaging. 1997;16(2):187–98.
39. Wang YX, Zhang YJ. Nonnegative matrix factorization: A comprehensive
review. IEEE Trans Knowl Data Eng. 2013;25(6):1336–53.
40. Sorber L, Van Barel M, De Lathauwer L. Structured data fusion. IEEE J
Selected Topics Signal Process. 2015;9(4):586–600.
41. Vervliet N, Debals O, Sorber L, Van Barel M, De Lathauwer L. Tensorlab
v3.0. 2016. http://www.tensorlab.net. Accessed 24 June 2016.
42. Nocedal J, Wright SJ. Numerical Optimization: Springer; 2006. ISBN:
0387400656.
43. Araújo MCU, Saldanha TCB, Galvão RKH, Yoneyama T, Chame HC, Visani V.
The successive projections algorithm for variable selection in
spectroscopic multicomponent analysis. Chemometrics Intell Lab Syst.
2001;57(2):65–73.
44. Gillis N. Successive nonnegative projection algorithm for robust
nonnegative blind source separation. SIAM J Imaging Sci. 2014;7(2):
1420–50.
45. Sauwen N, Acou M, Sima D, Maes F, Himmelreich U, Achten E,
Van Huffel S. A semi-automated segmentation framework for MRI based
brain tumor segmentation using regularized nonnegative matrix
factorization. In: Proceedings of the 12th International Conference on
Signal Image Technology & Internet Based Systems. Naples: IEEE; 2016. p.
88–95.
46. Bauer S, Wiest R, Nolte LP, Reyes M. A survey of MRI-based medical
image analysis for brain tumor studies. Phys Med Biol. 2013;58(13):97.
47. Di Costanzo A, Scarabino T, Trojsi F, Giannatempo GM, Popolizio T,
Catapano D, Bonavita S, Maggialetti N, Tosetti M, Salvolini U, d’Angelo V,
Tedeschi G. Multiparametric 3T MR approach to the assessment of
cerebral gliomas: tumor extent and malignancy. Neuroradiology.
2006;48(9):622–31.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
